These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2178236)
1. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. Chowdhury M; Taylor JP; Tada H; Rappaport J; Wong-Staal F; Amini S; Khalili K Oncogene; 1990 Dec; 5(12):1737-42. PubMed ID: 2178236 [TBL] [Abstract][Full Text] [Related]
2. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Chowdhury M; Kundu M; Khalili K Oncogene; 1993 Apr; 8(4):887-92. PubMed ID: 8384357 [TBL] [Abstract][Full Text] [Related]
3. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525 [TBL] [Abstract][Full Text] [Related]
4. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice. Gordon J; Del Valle L; Otte J; Khalili K Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901 [TBL] [Abstract][Full Text] [Related]
6. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Tada H; Rappaport J; Lashgari M; Amini S; Wong-Staal F; Khalili K Proc Natl Acad Sci U S A; 1990 May; 87(9):3479-83. PubMed ID: 2159152 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line. Remenick J; Radonovich MF; Brady JN J Virol; 1991 Oct; 65(10):5641-6. PubMed ID: 1654461 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif. Vacca A; Farina M; Maroder M; Alesse E; Screpanti I; Frati L; Gulino A Biochem Biophys Res Commun; 1994 Nov; 205(1):467-74. PubMed ID: 7999066 [TBL] [Abstract][Full Text] [Related]
9. Transduction of the human immunodeficiency virus type 1 promoter into human chromosomal DNA by adeno-associated virus: effects on promoter activity. Nahreini P; Mathews MB Virology; 1997 Jul; 234(1):42-50. PubMed ID: 9234945 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a mechanism of demyelination by human JC virus: negative transcriptional regulation of RNA and protein levels from myelin basic protein gene by large tumor antigen in human glioblastoma cells. Devireddy LR; Kumar KU; Pater MM; Pater A J Med Virol; 1996 Jul; 49(3):205-11. PubMed ID: 8818966 [TBL] [Abstract][Full Text] [Related]
11. Regulation of JCVL promoter function: evidence that a pentanucleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late promoter. Tada H; Lashgari MS; Khalili K Virology; 1991 Jan; 180(1):327-38. PubMed ID: 1845829 [TBL] [Abstract][Full Text] [Related]
12. Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HIV-1 Tat. Ursini MV; Lettieri T; Braddock M; Martini G Virology; 1993 Sep; 196(1):338-43. PubMed ID: 8356804 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs. Kashanchi F; Sadaie MR; Brady JN Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142 [TBL] [Abstract][Full Text] [Related]
14. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat. Robinson D; Elliott JF; Chang LJ Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987 [TBL] [Abstract][Full Text] [Related]
15. Dual NF1-requiring effect of human neurotropic JC virus composite pentanucleotide repeat elements on early and late viral gene expression. Liu M; Kumar KU; Pater MM; Pater A Virology; 1997 Jan; 227(1):7-12. PubMed ID: 9007053 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies. Mukhtar M; Duan L; Bagasra O; Pomerantz RJ Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098 [TBL] [Abstract][Full Text] [Related]
17. Identification of a cellular protein that binds to Tat-responsive element of TGF beta-1 promoter in glial cells. Thatikunta P; Sawaya BE; Denisova L; Cole C; Yusibova G; Johnson EM; Khalili K; Amini S J Cell Biochem; 1997 Dec; 67(4):466-77. PubMed ID: 9383706 [TBL] [Abstract][Full Text] [Related]
18. Human polyomavirus JCV late leader peptide region contains important regulatory elements. Akan I; Sariyer IK; Biffi R; Palermo V; Woolridge S; White MK; Amini S; Khalili K; Safak M Virology; 2006 May; 349(1):66-78. PubMed ID: 16497349 [TBL] [Abstract][Full Text] [Related]
19. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. Rittner K; Churcher MJ; Gait MJ; Karn J J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225 [TBL] [Abstract][Full Text] [Related]
20. Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Lashgari MS; Tada H; Amini S; Khalili K Virology; 1989 May; 170(1):292-5. PubMed ID: 2541545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]